Broncofar Plus Jarabe Report for Patients Like You

Filter by:

All
Start typing to see suggestions

patients

Home > Community Treatment Reports and Side Effects > Broncofar Plus Jarabe Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

What is Broncofar Plus Jarabe?

Broncofar Plus Jarabe is an international product containing anhydrous theophylline, salbutamol sulphate, ambroxol hydrochloride and hydroxyzine hydrochloride. It is a combination mucolytic, bronchodilator antiallergic therapy.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose	# of patients	# of patients with evaluations Efficacy	Major	Moderate	Slight	None	Can’t tell
Asthma	1	0

Mouse over the table for more information

Reported Stop Reasons

Why Patients Stopped Taking Broncofar Plus Jarabe (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Other	1
Course of treatment ended	1

See all 1 patient who’ve stopped taking Broncofar Plus Jarabe

Report created on May 26, 2012.